Neutralizing antibody and t-cell responses against sars-cov-2 wild-type and variants of concern in chronic obstructive pulmonary disease subjects after chadox-1/chadox-1 homologous vaccination: a preliminary study

HIGHLIGHTS

  • who: Warawut Chaiwong and colleagues from the Division of Pulmonary, Critical Care, and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand have published the article: Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study, in the Journal: Vaccines 2022, x of 16/06/2021
  • what: The authors aimed to determine the humoral and cellular immune responses after ChAdOx-1 vaccination in subjects with subjects and age . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?